Demographic and clinical characteristics for patients undergoing autologous hematopoietic cell transplantation
Characteristics . | N (%) . |
---|---|
Total transplanted | N = 40 (100.0%) |
Sex | |
Female | 5 (12.5%) |
Male | 35 (87.5%) |
Ethnicity | |
Hispanic or Latino | 9 (22.5%) |
Not Hispanic or Latino | 29 (72.5%) |
Unknown | 1 (2.5%) |
Not answered | 1 (2.5%) |
Race | |
Black or African American | 13 (32.5%) |
White | 24 (60.0%) |
Unknown | 3 (7.5%) |
Age, y | |
Median (range) | 46.9 (22.5-62.2) |
Performance status | |
100 | 11 (27.5%) |
90 | 20 (50.0%) |
80 | 7 (17.5%) |
70 | 2 (5.0%) |
Patient diagnosis | |
Hodgkin lymphoma | 15 (37.5%) |
Non-Hodgkin lymphoma | 25 (62.5%) |
Diffuse large B-cell lymphoma | 16 |
Plasmablastic lymphoma | 2 |
Burkitt or Burkitt-like lymphoma | 7 |
Disease stage at AHCT | |
Complete remission | 30 (75.0%) |
Partial remission | 9 (22.5%) |
Relapsed or progressive disease | 1 (2.5%) |
Characteristics . | N (%) . |
---|---|
Total transplanted | N = 40 (100.0%) |
Sex | |
Female | 5 (12.5%) |
Male | 35 (87.5%) |
Ethnicity | |
Hispanic or Latino | 9 (22.5%) |
Not Hispanic or Latino | 29 (72.5%) |
Unknown | 1 (2.5%) |
Not answered | 1 (2.5%) |
Race | |
Black or African American | 13 (32.5%) |
White | 24 (60.0%) |
Unknown | 3 (7.5%) |
Age, y | |
Median (range) | 46.9 (22.5-62.2) |
Performance status | |
100 | 11 (27.5%) |
90 | 20 (50.0%) |
80 | 7 (17.5%) |
70 | 2 (5.0%) |
Patient diagnosis | |
Hodgkin lymphoma | 15 (37.5%) |
Non-Hodgkin lymphoma | 25 (62.5%) |
Diffuse large B-cell lymphoma | 16 |
Plasmablastic lymphoma | 2 |
Burkitt or Burkitt-like lymphoma | 7 |
Disease stage at AHCT | |
Complete remission | 30 (75.0%) |
Partial remission | 9 (22.5%) |
Relapsed or progressive disease | 1 (2.5%) |